16.40
price up icon0.09%   0.03
after-market アフターアワーズ: 16.41 0.01 +0.06%
loading
前日終値:
$16.37
開ける:
$16.33
24時間の取引高:
313.06K
Relative Volume:
0.53
時価総額:
$845.98M
収益:
$107.46M
当期純損益:
$105.90M
株価収益率:
8.0884
EPS:
2.0276
ネットキャッシュフロー:
$238.50M
1週間 パフォーマンス:
+0.83%
1か月 パフォーマンス:
-0.45%
6か月 パフォーマンス:
-17.91%
1年 パフォーマンス:
+76.19%
1日の値動き範囲:
Value
$16.08
$16.44
1週間の範囲:
Value
$16.08
$16.60
52週間の値動き範囲:
Value
$9.10
$21.03

Theravance Biopharma Inc Stock (TBPH) Company Profile

Name
名前
Theravance Biopharma Inc
Name
セクター
Healthcare (1113)
Name
電話
650-808-6000
Name
住所
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
Name
職員
90
Name
Twitter
Name
次回の収益日
2026-05-14
Name
最新のSEC提出書
Name
TBPH's Discussions on Twitter

Compare TBPH vs VRTX, REGN, ARGX, ALNY, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
TBPH icon
TBPH
Theravance Biopharma Inc
16.41 843.92M 107.46M 105.90M 238.50M 2.0276
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
435.92 110.28B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
634.42 66.98B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
808.61 50.15B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
295.50 39.71B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
154.89 32.22B 742.00K -1.37B -1.07B -7.0731

Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-05 ダウングレード Oppenheimer Outperform → Perform
2026-03-04 ダウングレード B. Riley Securities Buy → Neutral
2025-12-03 開始されました Oppenheimer Outperform
2025-09-12 開始されました B. Riley Securities Buy
2024-08-06 ダウングレード Leerink Partners Outperform → Market Perform
2024-04-12 開始されました BTIG Research Buy
2024-01-08 ダウングレード Evercore ISI Outperform → In-line
2022-05-23 開始されました SVB Leerink Outperform
2021-11-05 アップグレード JP Morgan Underweight → Neutral
2021-09-15 ダウングレード JP Morgan Overweight → Underweight
2021-08-25 ダウングレード Morgan Stanley Overweight → Underweight
2021-08-24 ダウングレード Cowen Outperform → Market Perform
2020-10-14 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-07-07 開始されました JP Morgan Overweight
2020-06-15 開始されました Morgan Stanley Equal-Weight
2020-05-13 開始されました Cowen Outperform
2020-01-08 繰り返されました H.C. Wainwright Buy
2019-11-06 アップグレード Robert W. Baird Underperform → Neutral
2019-10-29 開始されました H.C. Wainwright Buy
2018-03-29 再開されました Piper Jaffray Overweight
2017-08-17 開始されました Evercore ISI Outperform
2017-06-16 開始されました Cantor Fitzgerald Overweight
2017-05-11 繰り返されました Needham Buy
2016-12-21 開始されました Needham Buy
2016-11-03 開始されました Piper Jaffray Overweight
2016-10-12 ダウングレード Robert W. Baird Neutral → Underperform
2016-08-03 ダウングレード BofA/Merrill Neutral → Underperform
2016-06-20 開始されました Guggenheim Buy
2016-06-20 繰り返されました Leerink Partners Outperform
2016-05-12 開始されました Leerink Partners Outperform
2016-05-05 ダウングレード BofA/Merrill Buy → Neutral
2015-02-03 アップグレード Robert W. Baird Underperform → Neutral
すべてを表示

Theravance Biopharma Inc (TBPH) 最新ニュース

pulisher
May 22, 2026

Theravance Biopharma (TBPH) CEO has shares withheld to cover RSU taxes - Stock Titan

May 22, 2026
pulisher
May 22, 2026

Theravance Biopharma (NASDAQ: TBPH) CFO has 8,670 shares withheld for RSU taxes - Stock Titan

May 22, 2026
pulisher
May 22, 2026

Theravance Biopharma (TBPH) SVP has shares withheld for RSU taxes - Stock Titan

May 22, 2026
pulisher
May 22, 2026

Theravance Biopharma (TBPH) SVP has 8,829 shares withheld for RSU tax - Stock Titan

May 22, 2026
pulisher
May 22, 2026

Theravance Biopharma (TBPH) SVP uses 5,678 shares to cover tax bill - Stock Titan

May 22, 2026
pulisher
May 18, 2026

Theravance Biopharma (TBPH) Q4 earnings and revenues lag estimates - MSN

May 18, 2026
pulisher
May 15, 2026

Behavioral Patterns of TBPH and Institutional Flows - Stock Traders Daily

May 15, 2026
pulisher
May 13, 2026

Are Options Traders Betting on a Big Move in Theravance Biopharma Stock? - TradingView

May 13, 2026
pulisher
May 11, 2026

BTIG Maintains Theravance Biopharma (TBPH) Buy Recommendation - MSN

May 11, 2026
pulisher
May 09, 2026

Here's why Theravance Biopharma (TBPH) is a strong momentum stock - MSN

May 09, 2026
pulisher
May 08, 2026

TBPH Q1 Earnings Beat Amid Strategic Restructuring & Pipeline Hurdle - sharewise.com

May 08, 2026
pulisher
May 08, 2026

BTIG Maintains Theravance Biopharma(TBPH.US) With Buy Rating, Maintains Target Price $21 - Moomoo

May 08, 2026
pulisher
May 08, 2026

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Strong Revenue Growth and Strategic Collaborations Point to Promising Future - DirectorsTalk Interviews

May 08, 2026
pulisher
May 07, 2026

Theravance Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 07, 2026
pulisher
May 07, 2026

Earnings Flash (TBPH) Theravance Biopharma, Inc. Reports Q1 Revenue $17.7M, vs. FactSet Est of $17.8M - marketscreener.com

May 07, 2026
pulisher
May 07, 2026

Theravance Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2026
pulisher
May 07, 2026

Theravance Biopharma (NASDAQ: TBPH) slashes R&D after ampreloxetine trial miss - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Theravance Biopharma reports Q1 2026 revenue $17.7M, narrows net loss to $4.9M - TradingView

May 07, 2026
pulisher
May 07, 2026

Ireland's Theravance Biopharma Q1 revenue beats estimates on YUPELRI growth - TradingView

May 07, 2026
pulisher
May 07, 2026

Theravance Bio: Q1 Earnings Snapshot - KTVB

May 07, 2026
pulisher
May 07, 2026

Theravance (NASDAQ: TBPH) targets $60–70M cash flow after major restructuring - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Theravance Biopharma: Confident Will Achieve $100 Million Milestone Payment Associated With 2026 Trelegy Net Sales >TBPH - Moomoo

May 07, 2026
pulisher
May 07, 2026

Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update - ChartMill

May 07, 2026
pulisher
May 07, 2026

Here's Why Theravance Biopharma (TBPH) is a Strong Momentum Stock - Yahoo Finance

May 07, 2026
pulisher
May 06, 2026

MSN Money - MSN

May 06, 2026
pulisher
May 04, 2026

(TBPH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

May 04, 2026
pulisher
May 04, 2026

Theravance's Q4 earnings and revenues miss estimates - MSN

May 04, 2026
pulisher
May 03, 2026

Theravance stock declines around 17% in three months: Here's why - MSN

May 03, 2026
pulisher
May 02, 2026

Theravance Biopharma (NASDAQ:TBPH) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat

May 02, 2026
pulisher
Apr 30, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc.TBPH - PR Newswire

Apr 30, 2026
pulisher
Apr 28, 2026

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc.TBPH - FinancialContent

Apr 28, 2026
pulisher
Apr 28, 2026

Theravance Biopharma (NASDAQ: TBPH) sets 2026 AGM votes on board, pay, auditor - Stock Titan

Apr 28, 2026
pulisher
Apr 28, 2026

A Pivotal Quarter for Theravance Biopharma (TBPH): Milestone Cash Influx and a Transition to Pure Commercial Play - AlphaStreet

Apr 28, 2026

Theravance Biopharma Inc (TBPH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$29.66
price down icon 1.49%
$92.29
price up icon 0.12%
$108.87
price up icon 2.60%
$53.85
price down icon 0.94%
ONC ONC
$302.59
price down icon 2.50%
$154.89
price up icon 2.21%
大文字化:     |  ボリューム (24 時間):